PCVX Kronos AI forecast
A 30-trading-day price forecast for Vaxcyte Inc. (PCVX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Vaxcyte Inc. at $57.08 on 2026-12-08, −5.9% from the last close of $60.67 on 2026-10-27. Eight out of ten sampled paths end between $54.46 and $59.52, and 1 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of PCVX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $63.44 | $58.84 | $68.24 |
| 2026-11-10 | $64.21 | $60.28 | $67.83 |
| 2026-11-17 | $63.39 | $57.67 | $65.52 |
| 2026-11-24 | $59.17 | $54.82 | $62.41 |
| 2026-12-01 | $57.19 | $54.77 | $61.63 |
| 2026-12-08 | $57.08 | $54.46 | $59.52 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for PCVX?
- Kronos AI's median forecast for PCVX is $57.08 in 30 trading days, −5.9% from the last close, with a 10–90% range of $54.46 to $59.52.
- Is the PCVX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.